Business · 29/08/2022Updated: 10/17/2026 · 1 min read
FDA Approves Product Under Priority Review Voucher for MOUNJARO (tirzepatide) Injection
Summary
The FDA has approved a product redeeming a priority review voucher for MOUNJARO (tirzepatide) injection, following the application's meeting of specific criteria, as mandated by the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →